Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology and risk prediction

    Restless legs syndrome (RLS) affects up to 10% of older adults. Their healthcare is impeded by delayed diagnosis and insufficient treatment. To advance disease prediction and find new entry points for therapy,...

    Barbara Schormair, Chen Zhao, Steven Bell, Maria Didriksen in Nature Genetics (2024)

  2. Article

    Open Access

    Diffuse myocardial fibrosis is uncommon in people with perinatally acquired human immunodeficiency virus infection

    Cardiovascular disease (CVD) remains a leading cause of death in people living with HIV. Myocardial fibrosis is well-described in HIV infection acquired in adulthood. We evaluate the burden of fibrosis by card...

    Jason L. Williams, Frances Hung, Elizabeth Jenista in AIDS Research and Therapy (2024)

  3. No Access

    Article

    Prognostic value of CT-derived coronary artery disease characteristics varies by ASCVD risk: insights from the PROMISE trial

    To compare the prognostic value of individual CT-derived coronary artery disease (CAD) characteristics across categories of clinical cardiovascular risk.

    Borek Foldyna, Thomas Mayrhofer, Michael T. Lu, Júlia Karády in European Radiology (2023)

  4. Article

    Open Access

    The association of accelerated epigenetic age with all-cause mortality in cardiac catheterization patients as mediated by vascular and cardiometabolic outcomes

    Epigenetic age is a DNA methylation-based biomarker of aging that is accurate across the lifespan and a range of cell types. The difference between epigenetic age and chronological age, termed age acceleration...

    Rong Jiang, Elizabeth R. Hauser, Lydia Coulter Kwee, Svati H. Shah in Clinical Epigenetics (2022)

  5. Article

    Open Access

    Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events

    There is increasing evidence that HFpEF is a heterogeneous clinical entity and distinct molecular pathways may contribute to pathophysiology. Leveraging unbiased proteomics to identify novel biomarkers, this s...

    Jessica A. Regan, Lauren K. Truby, Usman A. Tahir, Daniel H. Katz in Scientific Reports (2022)

  6. Article

    Open Access

    Multi-dimensional characterization of prediabetes in the Project Baseline Health Study

    We examined multi-dimensional clinical and laboratory data in participants with normoglycemia, prediabetes, and diabetes to identify characteristics of prediabetes and predictors of progression from prediabete...

    Ranee Chatterjee, Lydia Coulter Kwee, Neha Pagidipati in Cardiovascular Diabetology (2022)

  7. Article

    Open Access

    Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes

    Heart failure with reduced ejection fraction (HFrEF) is increasingly treated with medications for type 2 diabetes mellitus (T2DM). Whether metabolic derangements in HFrEF and T2DM are associated with different...

    Joseph B. Lerman, Stephanie N. Giamberardino, Adrian F. Hernandez in Scientific Reports (2022)

  8. Article

    Open Access

    Risk factors, transcriptomics, and outcomes of myocardial injury following lower extremity revascularization

    Myocardial injury after non-cardiac surgery (MINS) is common. We investigated the incidence and outcomes of MINS, and mechanistic underpinnings using pre-operative whole blood gene expression profiling in a pr...

    Nathaniel R. Smilowitz, MacIntosh Cornwell, Erik J. Offerman in Scientific Reports (2022)

  9. No Access

    Article

    Urine tricarboxylic acid cycle signatures of early-stage diabetic kidney disease

    Urine tricarboxylic acid (TCA) cycle organic anions (OAs) are elevated in diabetes and may be biomarkers for diabetic kidney disease (DKD) progression.

    Joseph Lunyera, Clarissa J. Diamantidis, Hayden B. Bosworth, Uptal D. Patel in Metabolomics (2021)

  10. Article

    Open Access

    Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy

    Whether differences in circulating long chain acylcarnitines (LCAC) are seen in heart failure (HF) patients with and without diabetes mellitus (DM), and whether these biomarkers report on exercise capacity and...

    Lauren K. Truby, Jessica A. Regan, Stephanie N. Giamberardino in Cardiovascular Diabetology (2021)

  11. Article

    Open Access

    Metabolites and diabetes remission after weight loss

    There is marked heterogeneity in the response to weight loss interventions with regards to weight loss amount and metabolic improvement. We sought to identify biomarkers predictive of type 2 diabetes remission...

    Lydia Coulter Kwee, Olga Ilkayeva, Michael J. Muehlbauer in Nutrition & Diabetes (2021)

  12. Article

    Open Access

    Novel plasma biomarkers improve discrimination of metabolic health independent of weight

    We sought to determine if novel plasma biomarkers improve traditionally defined metabolic health (MH) in predicting risk of cardiovascular disease (CVD) events irrespective of weight. Poor MH was defined in CA...

    Stephen Ellison, Jawan W. Abdulrahim, Lydia Coulter Kwee in Scientific Reports (2020)

  13. Article

    Open Access

    Evaluating the precision of EBF1 SNP x stress interaction association: sex, race, and age differences in a big harmonized data set of 28,026 participants

    In prior work, we identified a novel gene-by-stress association of EBF1’s common variation (SNP rs4704963) with obesity (i.e., hip, waist) in Whites, which was further strengthened through multiple replications u...

    Abanish Singh, Michael A. Babyak, Mario Sims, Solomon K. Musani in Translational Psychiatry (2020)

  14. No Access

    Article

    Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk

    Obesity is a significant international public health epidemic with major downstream consequences on morbidity and mortality. While lifestyle factors contribute, there is an evolving understanding of genomic an...

    Jessica A. Regan, Svati H. Shah in Current Cardiology Reports (2020)

  15. Article

    Open Access

    Rationale and design of “Hearts & Parks”: study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesity

    The prevalence of child and adolescent obesity and severe obesity continues to increase despite decades of policy and research aimed at prevention. Obesity strongly predicts cardiovascular and metabolic diseas...

    Sarah C. Armstrong, McAllister Windom, Nathan A. Bihlmeyer in BMC Pediatrics (2020)

  16. No Access

    Article

    Preliminary evidence of effects of potassium chloride on a metabolomic path to diabetes and cardiovascular disease

    Low potassium intake can affect cardiovascular disease (CVD) risk and cardiometabolic risk factors.

    Ranee Chatterjee, Clemontina A. Davenport, Lydia Kwee, David D’Alessio in Metabolomics (2020)

  17. Article

    Open Access

    Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements

    Changes in platelet physiology are associated with simultaneous changes in microRNA concentrations, suggesting a role for microRNA in platelet regulation. Here we investigated potential associations between mi...

    Kristian C. Becker, Lydia Coulter Kwee, Megan L. Neely in Scientific Reports (2020)

  18. Article

    Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Valérie Turcot, Yingchang Lu, Heather M. Highland, Claudia Schurmann in Nature Genetics (2019)

  19. Article

    Open Access

    Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes

    Angiopoietin-like 4 (ANGPTL4) is an endogenous inhibitor of lipoprotein lipase that modulates lipid levels, coronary atherosclerosis risk, and nutrient partitioning. We hypothesize that loss of ANGPTL4 functio...

    Viktoria Gusarova, Colm O’Dushlaine, Tanya M. Teslovich in Nature Communications (2018)

  20. Article

    Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

    In the version of this article originally published, one of the two authors with the name Wei Zhao was omitted from the author list and the affiliations for both authors were assigned to the single Wei Zhao in...

    Valérie Turcot, Yingchang Lu, Heather M. Highland, Claudia Schurmann in Nature Genetics (2018)

previous disabled Page of 2